682
Participants
Start Date
October 5, 2019
Primary Completion Date
February 7, 2022
Study Completion Date
February 7, 2022
VaxigripTetra®
Suspension for injection Injection intramuscular
Site 003, Gangwon-do
Site 002, Gwangju
Site 004, Gyeonggi-do
Site 005, Gyeonggi-do
Site 008, Gyeonggi-do
Site 011, Gyeonggi-do
Site 015, Gyeonggi-do
Site 006, Gyeongsangnam-do
Site 010, Gyeongsangnam-do
Site 009, Seoul
Site 012, Seoul
Site 014, Seoul
Lead Sponsor
Sanofi
INDUSTRY